3692:HKG
Hansoh Pharmaceutical Group Company Ltd
31,74 HKD
arrow_upward
+1,15%(+0,36) 1D
16 ოქტ, 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3692...
Open
31,72 HKD
High
32,44 HKD
Low
31,52 HKD
Mkt. cap
192,48 მლრ.
Avg. vol.
8,58 მლნ.
Volume
10,50 მლნ.
Dividend
1,53%
Quarterly dividend
0,12 HKD
Ex-dividend date
22 სექ. 2026
P/E ratio
24,51
52-wk high
44,22 HKD
52-wk low
28,06 HKD
EPS
1,30 HKD
No. of employees
10 ათ.
Open
31,72 HKD
High
32,44 HKD
Low
31,52 HKD
Mkt. cap
192,48 მლრ.
Avg. vol.
8,58 მლნ.
Volume
10,50 მლნ.
Dividend
1,53%
Quarterly dividend
0,12 HKD
Ex-dividend date
22 სექ. 2026
P/E ratio
24,51
52-wk high
44,22 HKD
52-wk low
28,06 HKD
EPS
1,30 HKD
No. of employees
10 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
14 საათის წინ
Hansoh Pharma stock gets HKD 47.82 consensus target
Simply Wall Street
·
14 საათის წინ
Could EMA Review Alter The Investment Case For Hansoh Pharma Stock (SEHK:3692)?
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
About Hansoh Pharmaceutical Group Company Ltd